ArticleJournal of molecular histology2026
Effects of human umbilical cord derived mesenchymal stem cells transplantation on ovarian function in rats with ovarian hyperstimulation syndrome.
Article in Journal of molecular histology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Ovarian hyperstimulation syndrome (OHSS) is a serious iatrogenic complication of assisted reproductive treatments, characterized by increased vascular permeability and fluid shifts leading to life-threatening conditions such as edema, hypovolemia, and acute respiratory distress syndrome. Mesenchymal stem cells (MSCs) are multipotent cells with antioxidant, anti-inflammatory, and immunomodulatory properties. In this study, the potential protective effects of human umbilical cord-derived MSCs (HUC-MSCs) were investigated in Wistar albino rats, in which an OHSS model was established. Hoechst 3342 -labeled MSCs were administered intraperitoneally to rats prior to human chorionic gonadotropin (hCG) stimulation to evaluate their potential prophylactic effect in the OHSS model. Ovarian tissues were evaluated histopathologically by light and electron microscopy. Serum levels of 17β-estradiol (E2) and interleukin-6 (IL-6) were also analyzed. Oedema, vascular dilation and haemorrhagic areas were evident in the OHSS group but decreased after MSC administration. Compared with controls, OHSS rats showed decreased follicular development and increased atretic follicles and corpus luteum structures. Vascular endothelial growth factor (VEGF) immunoreactivity differed significantly among the control, MSC treated and OHSS groups. In the OHSS group, E2 and IL-6 levels increased significantly but were significantly reduced following MSC administration. Our findings suggest that MSC administration may exert protective effects against ovarian damage associated with OHSS. However, further studies are necessary to clarify the potential role of MSCs in modulating OHSS pathophysiology.
Indexed as
Identifiers
41989604What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.